Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 06, 2023

Efficacy and Safety of Intravenous Imatinib in Patients With COVID-19 Acute Respiratory Distress Syndrome

Critical Care (London, England)


Additional Info

Critical Care (London, England)
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
Crit Care 2023 Jun 08;27(1)226, LN Atmowihardjo, JR Schippers, E Duijvelaar, IH Bartelink, PM Bet, NEL Swart, N van Rein, K Purdy, D Cavalla, A McElroy, S Fritchley, A Vonk Noordegraaf, H Endeman, P van Velzen, M Koopmans, HJ Bogaard, L Heunks, N Juffermans, MJ Schultz, PR Tuinman, LDJ Bos, J Aman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading